Patent Assignment
Reel/Frame 075737/0001
Release of Security Interest
Recorded: 2026-06-12
Pages: 89
Assignor
COCOON SA LLC
Executed: 2026-06-11
Assignees
APCINTEX LIMITED
1 FEDERAL STREET, 38TH FLOOR, BOSTON, MASSACHUSETTS, 02110
JANPIX LIMITED
1 FEDERAL STREET, 38TH FLOOR, BOSTON, MASSACHUSETTS, 02110
CAPELLA BIOSCIENCE LTD
1 FEDERAL STREET, 38TH FLOOR, BOSTON, MASSACHUSETTS, 02110
LOCKBODY THERAPEUTICS LTD
1 FEDERAL STREET, 38TH FLOOR, BOSTON, MASSACHUSETTS, 02110
ULTRAHUMAN TWO LIMITED
1 FEDERAL STREET, 38TH FLOOR, BOSTON, MASSACHUSETTS, 02110
ULTRAHUMAN FOUR LIMITED
1 FEDERAL STREET, 38TH FLOOR, BOSTON, MASSACHUSETTS, 02110
MORPHOGEN-IX LIMITED
1 FEDERAL STREET, 38TH FLOOR, BOSTON, MASSACHUSETTS, 02110
OREXIA THERAPEUTICS LIMITED
1 FEDERAL STREET, 38TH FLOOR, BOSTON, MASSACHUSETTS, 02110
CARDIOKINE BIOPHARMA LLC
1 FEDERAL STREET, 38TH FLOOR, BOSTON, MASSACHUSETTS, 02110
CENTESSA BIOSCIENCES, INC
1 FEDERAL STREET, 38TH FLOOR, BOSTON, MASSACHUSETTS, 02110
PEARLRIVER BIO GMBH
1 FEDERAL STREET, 38TH FLOOR, BOSTON, MASSACHUSETTS, 02110
Z FACTOR LIMITED
1 FEDERAL STREET, 38TH FLOOR, BOSTON, MASSACHUSETTS, 02110
Covered Properties
(56)
STAT Inhibitors and their Use in the Treatment and/or Prevention of Cancer
Application:
61/651,757 →
Salicylic Acid Derivatives, Pharmaceutically Acceptable Salt Thereof, Composition Thereof and Method of Use Thereof
Application:
16/451,883 →
Publication:
US US20190382422A1
Alpha Substituted Stat Inhibitors and Compositions Thereof
Application:
62/985,685 →
Stat Inhibitory Compounds and Compositions
Application:
62/985,678 →
Squaryl and Heterocycle Containing Stat Inhibitors and Compositions
Application:
62/985,679 →
Stat Inhibitory Compounds and Compositions
Application:
63/074,905 →
Antigen Binding Molecules That Bind Light
Application:
62/621,346 →
Antigen Binding Molecules That Bind LIGHT
Antigen Binding Molecules That Bind Light
Anti C-Met Antibodies
CD47 Binding Agents
Method of Using Anti-CD47 Antibody Molecules
Therapeutic Use of Bone Morphogenetic Proteins
Medium- or Macro-Cyclic Benzyl-Substituted Heterocycle Derivatives and Related Uses
Application:
63/074,220 →
Bicyclic-Heterocycle Derivatives and Related Uses
Application:
63/074,216 →
Formulations of Lixivaptan for the Treatment of Polycystic Disease
Formulations of Lixivaptan for the Treatment of Polycystic Kidney Disease
Application:
62/517,793 →
Formulations of Lixivaptan for the Treatment of Polycystic Disease
Application:
62/580,167 →
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
Application:
60/309,516 →
Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function
Application:
60/441,307 →
Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function
Application:
60/491,254 →
Fusion constructs and use of same to produce antibodies with increased Fc receptor binding affinity and effector function
Application:
60/495,142 →
Antigen Binding Molecules That Bind EGFR, Vectors Encoding Same, and Uses Thereof
Application:
15/965,143 →
Publication:
US US20190106497A1
Chimeric EGFR antibody, vectors encoding same, and uses thereof
Application:
60/650,115 →
Antigen binding molecules that bind EGFR, vectors encoding same, and uses thereof
Application:
60/836,371 →
Compounds and Their Use for the Treatment of ALPHA1-Antitrypsin Deficiency
Modified Serpins for the Treatment of Bleeding Disorders
Modified Serpins for the Treatment of Bleeding Disorders
Salicylic Acid Derivatives, Pharmaceutically Acceptable Salt Thereof, Composition Thereof and Method of Use Thereof
Salicylic Acid Derivatives, Pharmaceutically Acceptable Salt Thereof, Composition Thereof and Method of Use Thereof
Sulfonamide Compounds and Their Use as STAT5 Inhibitors
Anti-CD47 Antibody Molecules
Therapeutic Use of Bone Morphogenetic Proteins
Tricyclic Diazepine Vasopressin Antagonists and Oxytocin Antagonists
Patent:
5,516,774 →
Application:
08/254,822 →
Tricyclic Diazepine Vasopressin Antagonists and Oxytocin Antagonists
Patent:
5,624,923 →
Application:
08/468,737 →
Vasopressin Antagonist and Diuretic Combination
Patent:
6,420,358 →
Application:
09/669,461 →
Vasopressin Antagonist and Diuretic Combination
Vasopressin antagonist formulation and process
Patent:
6,352,718 →
Application:
09/668,883 →
Compositions for Delivery of Insoluble Agents
Pharmaceutical Carrier Formulation
Patent:
6,437,006 →
Application:
09/668,970 →
Glycosylation Engineering of Antibodies for Improving Antibody-Dependent Cellular Cytotoxicity
Patent:
6,602,684 →
Application:
09/294,584 →
Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity
Fusion Constructs and Use of Same to Produce Antibodies with Increased Fc Receptor Binding Affinity and Effector Function
Fusion Constructs and Use of Same to Produce Antibodies with Increased Fc Receptor Binding Affinity and Effector Function
Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, and Uses Thereof
Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, and Uses Thereof
Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, and Uses Thereof
Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, and Uses Thereof
Antigen Binding Molecules That Bind EGFR, Vectors Encoding Same, and Uses Thereof
Antigen Binding Molecules That Bind EGFR, Vectors Encoding Same, and Uses Thereof
Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, and Uses Thereof
Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, and Uses Thereof
Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, and Uses Thereof
Antigen Binding Molecules That Bind Egfr, Vectors Encoding Same, and Uses Thereof
Antigen Binding Molecules That Bind EGFR, Vectors Encoding Same, and Uses Thereof
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 21, 2003
From: UMANA, PABLO; BRUENKER, PETER; FERRARA, CLAUDIA; SUTER, TOBIAS
To: GLYCART BIOTECHNOLGY AG
Reel/Frame 014537/0735 →
Assignment of Assignor's Interest
Apr 20, 2004
From: UMANA, PABLO; BRUENKER, PETER; FERRARA, CLAUDIA; SUTER, TOBIAS
To: GLYCART BIOTECHNOLGY AG
Reel/Frame 014540/0542 →
Assignment of Assignor's Interest
May 24, 2004
From: UMANA, PABLO; BRUENKER, PETER; FERRARA, CLAUDIA; SUTER, TOBIAS
To: GLYCART BIOTECHNOLOGY AG
Reel/Frame 015387/0258 →
Assignment of Assignor's Interest
May 24, 2004
From: UMANA, PABLO; BRUENKER, PETER; FERRARA, CLAUDIA; SUTER, TOBIAS
To: GLYCART BIOTECHNOLOGY AG
Reel/Frame 015367/0657 →
Assignment of Assignor's Interest
Apr 25, 2005
From: UMANA, PABLO; MOSSNER, EKKEHARD
To: GLYCART BIOTECHNOLOGY AG
Reel/Frame 015946/0231 →
Assignment of Assignor's Interest
Jul 20, 2007
From: UMANA, PABLO; MOSSNER, EKKEHARD
To: GLYCART BIOTECHNOLOGY AG
Reel/Frame 019584/0424 →
Confirmatory License
Jul 1, 2015
From: INDIANA UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 036042/0546 →
Assignment of Assignor's Interest
Sep 20, 2016
From: HUNTINGTON, JAMES ANDREW; POLDERDIJK, STEPHANIE; BAGLIN, TREVOR
To: CAMBRIDGE ENTERPRISE LIMITED
Reel/Frame 039785/0296 →
Assignment of Assignor's Interest
May 24, 2018
From: PELLEGRINI, LORENZO
To: PALLADIO BIOSCIENCES, INC.
Reel/Frame 045897/0751 →
Assignment of Assignor's Interest
Jul 2, 2018
From: HUNTINGTON, JAMES ANDREW; POLDERDIJK, STÉPHANIE; BAGLIN, TREVOR
To: CAMBRIDGE ENTERPRISE LIMITED
Reel/Frame 046254/0403 →
Assignment of Assignor's Interest
Jan 17, 2019
From: HOLMES, STEVE
To: CAPELLA BIOSCIENCE LTD.
Reel/Frame 048044/0697 →
Assignment of Assignor's Interest
Apr 24, 2019
From: HOLMES, STEVE
To: CAPELLA BIOSCIENCE LTD.
Reel/Frame 048977/0906 →
Assignment of Assignor's Interest
Dec 26, 2019
From: GUNNING, PATRICK THOMAS; HAFTCHENARY, SINA; PAGE, BRENT DAVID GEORGE
To: THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO
Reel/Frame 051366/0179 →
Assignment of Assignor's Interest
Dec 26, 2019
From: WEISS, SAMUEL; LUCHMAN, HEMA ARTEE
To: UTI LIMITED PARTNERSHIP
Reel/Frame 051418/0169 →
Assignment of Assignor's Interest
Dec 26, 2019
From: FISHEL, MELISSA L.
To: INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION
Reel/Frame 051366/0212 →
Assignment of Assignor's Interest
Jan 22, 2020
From: FISHEL, MELISSA L.
To: INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION
Reel/Frame 051582/0400 →
Assignment of Assignor's Interest
Jan 22, 2020
From: GUNNING, PATRICK THOMAS; HAFTCHENARY, SINA; PAGE, BRENT DAVID GEORGE
To: THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO
Reel/Frame 051582/0304 →
Assignment of Assignor's Interest
Jan 22, 2020
From: WEISS, SAMUEL; LUCHMAN, HEMA ARTEE
To: UTI LIMITED PARTNERSHIP
Reel/Frame 051664/0915 →
Assignment of Assignor's Interest
Jun 3, 2020
From: FLECK, ROMAN; PROUDFOOT, JOHN; OMEARA, JEFF; GUNNING, PATRICK THOMAS
To: JANPIX, LTD.
Reel/Frame 052824/0423 →
Assignment of Assignor's Interest
Jun 3, 2020
From: FLECK, ROMAN; PROUDFOOT, JOHN; OMEARA, JEFF; GNANASEKARAN, KRISHNA KUMAR
To: JANPIX, LTD.
Reel/Frame 052824/0342 →
Assignment of Assignor's Interest
Jun 22, 2020
From: FLECK, ROMAN; PROUDFOOT, JOHN; GNANASEKARAN, KRISHNA KUMAR; GUNNING, PATRICK THOMAS
To: JANPIX, LTD.
Reel/Frame 053000/0895 →
Assignment of Assignor's Interest
Jun 30, 2020
From: FINLAY, WILLIAM JAMES JONATHAN
To: ULTRAHUMAN FOUR LIMITED
Reel/Frame 053089/0938 →
Assignment of Assignor's Interest
Sep 23, 2020
From: FINLAY, WILLIAM JAMES JONATHAN
To: ULTRAHUMAN SIX LIMITED
Reel/Frame 053856/0961 →
Assignment of Assignor's Interest
Sep 23, 2020
From: FLECK, ROMAN; PROUDFOOT, JOHN; OMEARA, JEFF; GUNNING, PATRICK THOMAS
To: JANPIX, LTD.
Reel/Frame 053854/0295 →
Assignment of Assignor's Interest
Sep 29, 2020
From: FINLAY, WILLIAM JAMES JONATHAN
To: ULTRAHUMAN TWO LIMITED
Reel/Frame 053913/0676 →